Texas Ropes in Nearly $4 billion in Pharma-Bio Capital Investment
Texas Ropes in Nearly $4 billion in Pharma-Bio Capital Investment
Attachment: Pharma Texas
SUGAR LAND--January 19, 2016--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)--The Pharma-Bio Industry is not usually the first thing that comes to mind when one mentions Texas. But beyond the smoke stacks of the hundreds of the state's chemical processing plants and refineries are a surprising number of life science plants and research centers. Within this article: Details of large pharma-bio projects in Texas. Additional companies: Novartis (NYSE:NVS), Allergan PLC (NYSE:AGN)
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- Greater Houston Boasts $4 Billion in Q4 Project Kickoffs
- Texas Ropes in More Than $4 Billion in Pharmaceutical-Biotech Capital Inves...
- Beyond the Smoke Stacks: Texas Ropes in $4 Billion Pharma-Bio Investment
- Top 10 U.S. States Land $37.7 Billion in Active Pharmaceutical-Biotech Indu...
- No Wrinkles in Actavis' $66 Billion Deal to Buy Botox Maker Allergan